Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

The effects of long-term opioid treatment on the immune system in chronic non-cancer pain patients: A systematic review

Research output: Contribution to journalReviewResearchpeer-review

DOI

  1. Von Frey testing revisited - provision of an online algorithm for improved accuracy of 50% thresholds

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Medication-overuse headache: The effect of a patient educational programme-A randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Complete withdrawal is the most feasible treatment for medication-overuse headache: A randomized controlled open-label trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Poor concordance between liver stiffness and non-invasive fibrosis scores in HIV infection without viral hepatitis

    Research output: Contribution to journalShort surveyResearchpeer-review

  2. Cardiac chamber volumes and left ventricular mass in people living with HIV and matched uninfected controls

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Methylphenidate as Needed for Fatigue in Patients With Advanced Cancer. A Prospective, Double-Blind, and Placebo-Controlled Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Validation of a Battery of Neuropsychological Tests for Patients With Metastatic Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND AND OBJECTIVE: Opioids have been increasingly prescribed for chronic non-cancer pain (CNCP). An association between long-term opioid treatment (L-TOT) of CNCP patients and suppression of both the innate and the adaptive immune system has been proposed. This systematic review aims at investigating the effects of L-TOT on the immune system in CNCP patients.

DATABASES AND DATA TREATMENT: A systematic search of MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and the CINAHL for relevant articles was performed. Studies examining measures of both the innate and the adaptive immune system in adult CNCP patients in L-TOT (≥4 weeks of intake) were included. Outcomes and the level of evidence were analyzed.

RESULTS: Three-hundred-eighty-two studies were identified; however, 376 were excluded (352 inappropriate methodology, 21 duplicates, 3 full-text could not be obtained) and one RCT and five cross-sectional studies were included and analyzed. L-TOT compared with no treatment was associated with a lower percentage of NK cells, a lower absolute number of CD56bright NK cells, a higher absolute number of IL-2 activated NK cells and a higher concentration of IL-1β as a response to toll-like receptor (TLR) agonists stimulation (Pam3CSK4, LPS, Imiquimod). No other significant differences were reported. Generalizability of the results was limited due to inconsistency of outcomes and an overall low quality of the studies.

CONCLUSIONS: L-TOT may alter the immune system in CNCP patients, but the level of evidence is still weak. More studies are needed to clarify the impact of L-TOT on immune system function.

Original languageEnglish
JournalEuropean journal of pain
Volume24
Issue number3
Pages (from-to)481-496
Number of pages16
ISSN1090-3801
DOIs
Publication statusPublished - Mar 2020

ID: 58341919